DETAILED ACTION
Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Drawings
The Drawings filed 13 May 2025 are approved by the examiner.
Information Disclosure Statement
The information disclosure statement(s) (IDS) is/are in compliance with the provisions of 37 CFR 1.97. Accordingly, the information disclosure statement(s) is/are being considered by the examiner and an initialed copy is attached.
Priority
Receipt is acknowledged of the certified copies of papers required by 37 CFR 1.55.
Citation Notation
The following citations are made for the convenience of the reader:
Citations to PG publications are made to paragraph number under the ¶ format. Citations to other publications made under the format “ col 1/2” or pp 1 are directed to column and line number or to a page - whichever is appropriate. It is noted that any reference to a figure or a table is also directed to any accompanying text in the specification or the document. Notwithstanding those citations, the reference(s) is (are) relied upon for the teachings as a whole.
Claim Objections
Claims 2-3 and 8-9 are objected to because of the following informalities: the reference discrepancy between “the flakes” and “the plurality of flakes” throughout the claims. Appropriate correction is required.
Election/Restrictions
Applicant’s election without traverse of Group I in the reply filed on 18 August 2026 is acknowledged. Claims 10-24 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected invention, there being no allowable generic or linking claim. Election was made without traverse in the reply filed on 18 August 2026.
Double Patenting
The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969).
A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b).
The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13.
The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer.
Claims 2-6, 8 and 9 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-10 of U.S. Patent No. US-12331410-B2. Claims 2-9 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-8 and 10-16 of U.S. Patent No. US-12129460-B2. Although the claims at issue are not identical, they are not patentably distinct from each other because the instant discloses similar dehydrogenated flakes with similar structural and Raman spectra patterns – thus it would have been well within the purview of a skilled artisan to select and optimize the known variables to achieve a similar end-product for the benefit of gain of enhancing the conductivity and stability. Further, there is no evidence nor teaching that the selection and optimization of the composition to arrive at the known electrode would be repugnant to a skilled artisan.
Claim Rejections - 35 USC § 112
The following is a quotation of 35 U.S.C. 112(b):
(b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention.
The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph:
The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention.
Claims 2-9 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention.
Claim 2 recites the limitation "the dehydrogenated graphite" in lines 5 and 6. There is insufficient antecedent basis for this limitation in the claim. Claims 3-9 are dependent on claim 2 thus inherit the same deficiency.
Claim 3 recites the limitation "the coefficient of determination" in line 2. There is insufficient antecedent basis for this limitation in the claim.
Claim Rejections - 35 USC § 103
The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action:
A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made.
Examiner’s remarks:
The “dehydrogenated” limitation in independent claim 2 is construed as encompassing any level of dehydrogenation (such as a partial dehydrogenation).
Regarding the claimed property and/or spectroscopy values such as the defect density and the coefficient of determination in the claims, if a prior art reference teaches the substantially identical structure/material/product, it would be reasonable that the same function, spectroscopy and/property would be imparted or exhibited. See MPEP 2112.01.
Claim(s) 2-9 are rejected under 35 U.S.C. 103 as being unpatentable over Nazarpour (US20180155520, cited in the IDS).
Claims 2-3 and 8: Nazarpour discloses an electrode with (a) a plurality of graphite/graphene flakes with at least one flake having 2-10 layers and a particle size greater than 10 microns such as 11-25 microns, (b) a defect density based on a range of G/D ratios such as 20, (c) the sp2 and sp3 features, (d) the non-hydrogen functional group, (e) the dehydrogenation feature and (f) various end-products such as electrodes (abs, Figs 3-5 with accompanying text, and ¶1-3, 35-38, 56-63, 65-74, 86-88, 108). The Nazarpour reference discloses the claimed invention with various end-product applications comprising the composition but does not disclose the claimed electrode with the composition with enough specificity to anticipate the instant invention. Nevertheless, given that Nazarpour discloses the electrode as an existing end-product, it would have been obvious to one of ordinary skill in the chemical art at the time of the invention to apply the claimed composition to the claimed electrode end-product since Nazarpour teaches both the composition and the electrode. Here, Nazarpour discloses both the claimed composition and electrode and there is no evidence nor teaching that the selection of the application of the composition to arrive at the known electrode would be repugnant to a skilled artisan. Further, obviousness only requires a reasonable expectation of success. See MPEP 2143.
Claim 4: Nazarpour discloses a flake with a dimension greater than 10 microns (¶35, 40, 55-61, 108 and Figs 3 and 4 with accompanying text).
Claims 5-7 and 9: Nazarpour disclose bi-layers flakes, the wrinkling feature, the functionalization and a range of D/G ratios (Fig 3 with accompanying text and ¶65-74, 86-88, 108).
Claim(s) 2-9 are rejected under 35 U.S.C. 103 as being unpatentable over Kobayashi (US-20140202744-A1, cited in the IDS).
Claims 2-3 and 8-9: Kobayashi discloses a conductive composition for electrodes with (a) a plurality of graphite/graphene flakes with at least one flake having a thickness of less than 100 nm and a size greater than 150 nm, (b) a defect density based on a range of G/D ratio greater than 1.8 which corresponds to a D/G ratio of less than 0.55, (c) the sp2 and sp3 features and (d) the crosslinking pattern with mutual bonding schematic (abs, Fig 2 with accompanying text, and ¶1, 9-11, 30-35 and examples). The Kobayashi reference discloses the claimed invention but does not explicitly disclose the claimed D/G ratio and structural ranges. Given that the Kobayashi reference discloses ratios and ranges that overlap with the presently claimed ratios and ranges, it would have been obvious to one of ordinary skill in the art at the time of the invention to utilize any of the taught ratios and ranges, including those presently claimed, to obtain a suitable composition. According to MPEP 2131.03 and MPEP 2144.05, it would have been obvious to one of ordinary skill in the art at the time the invention was made to select the portion of the prior art's range which is within the range of applicant's claims because it has been held to be obvious to select a value in a known range by optimization for the best results. Thus, it would have been obvious to one of ordinary skill in the art at the time of the invention to optimize the D/G and structural variables with the benefit gain of enhancing the conductivity and stability parameters (¶8). Further, obviousness only requires a reasonable expectation of success and there is no evidence nor teaching that the selection or optimization of the claimed components would be repugnant to a skilled artisan.
Claim 4: Kobayashi discloses a flake with a dimension greater than 150 nm such as in the micrometer ranges (¶9-11 and Fig 2 with accompanying text).
Claims 5-7: Kobayashi disclose flakes with a thickness of less than 100 nm, the wrinkling feature and a range of D/G ratios (Fig 2 with accompanying text and ¶9-11, 30-35).
Conclusion
Any inquiry concerning this communication or earlier communications from the examiner should be directed to TRI V NGUYEN whose telephone number is (571)272-6965. The examiner can normally be reached M-F 9-5.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Arrie Lanee Reuthers can be reached on 571.272.7026. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/TRI V NGUYEN/ Primary Examiner, Art Unit 1764